As a company grows from pre-IPO to commercialization, the investor relations function must evolve to meet the demands of each stage. This session will explore the three key phases of IR development—from early-stage, small, and scrappy teams to structured functions supporting a commercialized public company. Gain actionable insights on building processes, defining roles, and scaling effectively to meet organizational needs at every stage of growth.
The three main stages discussed will be:
- Pre-IPO: Managing communications and IR as a small, agile team with no commercial products and preparing to go public.
- Clinical-Stage Public Company: Once public, separating functions like corporate comms and IR, while establishing structured processes such as quarterly earnings reporting.
- Commercial Public Company: Scaling functions to include navigating the FDA, government affairs, and product communications, while navigating the complexities of revenue reporting and stakeholder engagement.
